Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stoter

Showing results (131-140 of 249) with videos related to

Pageof 25
Sort By:
Progress in Clinical and Biological Research|January 1, 1992
Treatment of disseminated renal cell cancer with combinations of interleukin-2, lymphokine-activated killer cells, and alpha-interferonG Stoter, S H Goey, D Batchelor, et al.
Breast Cancer Research and Treatment|May 1, 1995
Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancerM Bontenbal, A S Planting, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapyR de Wit, M E van der Burg, A van den Gaast, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Phase II trial with Brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: a study of the Early Clinical Trials Group of the EORTCP F Dodion, T Wagener, G Stoter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II studyG Stoter, S Aamdal, S Rodenhuis, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|August 11, 1998
Liquid chromatographic determination of irinotecan and three major metabolites in human plasma, urine and fecesA Sparreboom, P de Bruijn, M J de Jonge, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 6, 1990
[Cured of testicular cancer; does life just go on?]A Koopman, C P Vendrik, D T Sleyfer, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micellesL van Zuylen, M O Karlsson, J Verweij, et al.
Neurology|January 1, 1996
Peripheral neurotoxicity induced by docetaxelP H Hilkens, J Verweij, G Stoter, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1982
An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancerJ A Child, A V Bono, S D Fossa, et al.
Pageof 25

Showing results (131-140 of 249) with videos related to

Sort By:
Pageof 25
Progress in Clinical and Biological Research|January 1, 1992
Treatment of disseminated renal cell cancer with combinations of interleukin-2, lymphokine-activated killer cells, and alpha-interferonG Stoter, S H Goey, D Batchelor, et al.
Breast Cancer Research and Treatment|May 1, 1995
Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancerM Bontenbal, A S Planting, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapyR de Wit, M E van der Burg, A van den Gaast, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Phase II trial with Brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: a study of the Early Clinical Trials Group of the EORTCP F Dodion, T Wagener, G Stoter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II studyG Stoter, S Aamdal, S Rodenhuis, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|August 11, 1998
Liquid chromatographic determination of irinotecan and three major metabolites in human plasma, urine and fecesA Sparreboom, P de Bruijn, M J de Jonge, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 6, 1990
[Cured of testicular cancer; does life just go on?]A Koopman, C P Vendrik, D T Sleyfer, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micellesL van Zuylen, M O Karlsson, J Verweij, et al.
Neurology|January 1, 1996
Peripheral neurotoxicity induced by docetaxelP H Hilkens, J Verweij, G Stoter, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1982
An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancerJ A Child, A V Bono, S D Fossa, et al.
Pageof 25